HIGHLIGHTS
- who: Kostas Palamaris and collaborators from the First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece have published the article: Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases, in the Journal: (JOURNAL) of 14/08/2022
- what: In this case series, we present a wide range of kidney lesions associated with ICIs.
SUMMARY
PD-1/PD-L1/PD-L2 and CTLA-4/CD80/CD86 axes act as intrinsic brakes that enable tumor cells to evade recognition by the immune system and hinder immune_response . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.